Joyonna Gamble-George, Ph.D.

Affiliations: 
2007-2009 VA Bay Pines Healthcare System 
 2007-2009 University of South Florida, Tampa, FL, United States 
 2009-2011 Meharry Medical College, Nashville, TN, United States 
 2011-2016 Vanderbilt University, Nashville, TN 
 2016-2018 University of Florida College of Medicine/McKnight Brain Institute 
 2019-2021 National Institutes of Health, Bethesda, MD 
Website:
https://www.joyonnagamble.com/
Google:
"Joyonna Gamble-George"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gamble-George JC, Longenecker CT, Webel AR, et al. (2020) ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Progress in Cardiovascular Diseases. 63: 79-91
Miller DR, Shaerzadeh F, Phan L, et al. (2018) HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia
Gaskill PJ, Miller DR, Gamble-George J, et al. (2017) HIV, Tat and dopamine transmission. Neurobiology of Disease. 105: 51-73
Gamble-George JC, Baldi R, Halladay L, et al. (2016) Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife. 5
Butler B, Gamble-George J, Prins P, et al. (2014) Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice. Journal of Addiction & Prevention. 2
Bluett RJ, Gamble-George JC, Hermanson DJ, et al. (2014) Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Translational Psychiatry. 4: e408
Hermanson DJ, Gamble-George JC, Marnett LJ, et al. (2014) Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. Trends in Pharmacological Sciences. 35: 358-67
Ramikie TS, Nyilas R, Bluett RJ, et al. (2014) Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron. 81: 1111-25
Hermanson DJ, Hartley ND, Gamble-George J, et al. (2013) Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nature Neuroscience. 16: 1291-8
Gamble-George JC, Conger JR, Hartley ND, et al. (2013) Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. Psychopharmacology. 228: 401-9
See more...